Atyr Pharma Company Profile (NASDAQ:LIFE)

About Atyr Pharma

Atyr Pharma logoaTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The Company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The Company is investigating Resolaris in patients with LGMD2B. The Company is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The Company has not generated any revenues.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: LIFE
  • CUSIP: 53217V10
Key Metrics:
  • Previous Close: $2.97
  • 50 Day Moving Average: $3.08
  • 200 Day Moving Average: $3.62
  • 52-Week Range: $2.48 - $19.67
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.22
  • P/E Growth: 0.00
  • Market Cap: $69.97M
  • Outstanding Shares: 23,718,000
  • Beta: 3.26
Additional Links:
Companies Related to Atyr Pharma:

Analyst Ratings

Consensus Ratings for Atyr Pharma (NASDAQ:LIFE) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $7.00 (139.73% upside)

Analysts' Ratings History for Atyr Pharma (NASDAQ:LIFE)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Citigroup Inc.Boost Price TargetNeutral$3.00 -> $4.00View Rating Details
8/11/2016JPMorgan Chase & Co.Lower Price TargetOverweight$15.00 -> $10.00View Rating Details
5/12/2016BMO Capital MarketsReiterated RatingHoldView Rating Details
3/31/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Atyr Pharma (NASDAQ:LIFE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/10/2016Q216($0.71)($0.65)ViewN/AView Earnings Details
5/11/2016Q1($0.70)($0.68)ViewN/AView Earnings Details
3/30/2016Q4($0.52)($0.70)ViewN/AView Earnings Details
11/10/2015Q3($0.48)($0.48)ViewN/AView Earnings Details
8/12/2015Q215($0.53)($0.74)ViewN/AView Earnings Details
6/18/2015Q115($0.41)($9.39)ViewN/AView Earnings Details
11/5/2013Q313$0.97$1.02$926.10 million$936.00 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.96$0.72$952.06 million$944.00 millionViewN/AView Earnings Details
5/2/2013Q1 2013$1.04$1.07$958.56 million$963.00 millionViewN/AView Earnings Details
2/4/2013Q4 2012$1.11$1.11$988.85 million$998.90 millionViewN/AView Earnings Details
11/1/2012Q312$0.89$0.92$907.91 million$911.00 millionViewN/AView Earnings Details
7/31/2012$0.97$0.96ViewN/AView Earnings Details
2/7/2012$1.04$1.06ViewN/AView Earnings Details
10/25/2011$0.88$0.94ViewN/AView Earnings Details
7/28/2011$0.95$0.89ViewN/AView Earnings Details
4/26/2011$0.85$0.85ViewN/AView Earnings Details
2/3/2011$0.87$0.90ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Atyr Pharma (NASDAQ:LIFE)
Current Year EPS Consensus Estimate: $-2.56 EPS
Next Year EPS Consensus Estimate: $-2.40 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.70)($0.70)($0.70)
Q2 20161($0.68)($0.68)($0.68)
Q3 20161($0.66)($0.66)($0.66)
Q4 20161($0.66)($0.66)($0.66)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Atyr Pharma (NASDAQ:LIFE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Atyr Pharma (NASDAQ:LIFE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2016Grove MatsuokaInsiderBuy12,412$3.04$37,732.48View SEC Filing  
4/14/2016Paul SchimmelDirectorBuy66,219$4.18$276,795.42View SEC Filing  
4/13/2016Paul SchimmelDirectorBuy9,835$3.85$37,864.75View SEC Filing  
4/12/2016Paul SchimmelDirectorBuy9,127$3.71$33,861.17View SEC Filing  
4/11/2016Paul SchimmelDirectorBuy32,659$3.57$116,592.63View SEC Filing  
4/8/2016Paul SchimmelDirectorBuy85,000$3.22$273,700.00View SEC Filing  
4/7/2016Paul SchimmelDirectorBuy40,000$3.19$127,600.00View SEC Filing  
4/6/2016Paul SchimmelDirectorBuy25,000$3.20$80,000.00View SEC Filing  
4/5/2016John MendleinCEOBuy2,500$3.55$8,875.00View SEC Filing  
4/5/2016Paul SchimmelDirectorBuy25,000$3.52$88,000.00View SEC Filing  
5/12/2015James E FlynnInsiderBuy50,000$14.00$700,000.00View SEC Filing  
5/12/2015Sofinnova Venture Partners Ix,Major ShareholderBuy320,000$14.00$4,480,000.00View SEC Filing  
5/29/2013David C UprichardDirectorSell2,010$74.04$148,820.40View SEC Filing  
5/28/2013John A CottinghamInsiderSell60,000$74.03$4,441,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Atyr Pharma (NASDAQ:LIFE)
DateHeadline
News IconHC Stocks Reports Analysis - aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE)
sharemarketupdates.com - August 30 at 5:56 PM
live-pr.com logoNew Market Research Report: aTyr Pharma, Inc. (LIFE) - Financial and Strategic SWOT Analysis Review (NASDAQ:LIFE)
www.live-pr.com - August 26 at 8:57 AM
finance.yahoo.com logoATYR PHARMA INC Financials (NASDAQ:LIFE)
finance.yahoo.com - August 19 at 5:54 PM
News IconInstitutions Have Decreased Their Ownership of aTyr Pharma Inc. (NASDAQ:LIFE) - Post News (NASDAQ:LIFE)
www.kentuckypostnews.com - August 18 at 5:58 PM
rttnews.com logoMNK Opens Wallet, CYNA Awaits Parkinson's Drug Data, 3rd Time's A Charm For HRTX (NASDAQ:LIFE)
www.rttnews.com - August 11 at 9:02 AM
finance.yahoo.com logoaTyr Pharma Inc. (LIFE) (NASDAQ:LIFE)
finance.yahoo.com - August 10 at 6:17 PM
prnewswire.com logoaTyr Pharma Announces Second Quarter 2016 Operating Results (NASDAQ:LIFE)
www.prnewswire.com - August 10 at 6:17 PM
sg.finance.yahoo.com logoAtyr Pharma reports 2Q loss (NASDAQ:LIFE)
sg.finance.yahoo.com - August 10 at 6:17 PM
finance.yahoo.com logo4:16 pm aTyr Pharma reports 2Q16 net loss per share of ($0.65) vs. ($0.74) year ago; no revenue (NASDAQ:LIFE)
finance.yahoo.com - August 10 at 6:17 PM
biz.yahoo.com logoATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:LIFE)
biz.yahoo.com - August 10 at 6:17 PM
fxpips.com logoMarket Review – Manufacturing Stocks Gainers, Losers (NASDAQ:LIFE)
www.fxpips.com - August 2 at 10:46 AM
investing.com logoaTyr Pharma Technicals Signal Stock Is Set To Deliver (NASDAQ:LIFE)
www.investing.com - July 31 at 10:07 AM
News IconHC Stocks Judgment: aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE)
sharemarketupdates.com - July 26 at 6:11 PM
News IconChecking in on Stock Volatility for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - July 23 at 9:55 AM
streetupdates.com logoAnalysts Reviewing Stocks: InspireMD, Inc. (NYSEMKT:NSPR) , aTyr Pharma, Inc. (NASDAQ:LIFE) - Street Updates (NASDAQ:LIFE)
www.streetupdates.com - July 23 at 9:55 AM
News IconStock Moving Lower for the Month; Investor Update on aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - July 20 at 10:28 PM
News IconHeightened Volatility Spotted on Shares of: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - July 20 at 10:28 PM
News IconaTyr Pharma Inc's Trend Up, Especially After Today's Strong Session - Press Telegraph (NASDAQ:LIFE)
presstelegraph.com - July 20 at 10:28 PM
bizjournals.com logoBach Pharma Appoints Kelly Blackburn as Chief Executive Officer (NASDAQ:LIFE)
www.bizjournals.com - July 15 at 5:01 PM
News IconAtyr Pharma Incorporated (NASDAQ:LIFE) Sellers Covered 6.41% of Their Shorts - Press Telegraph (NASDAQ:LIFE)
presstelegraph.com - July 15 at 10:03 AM
News IconStock Volatility Focus for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - July 12 at 6:11 PM
News IconHow Many aTyr Pharma Inc (NASDAQ:LIFE)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:LIFE)
www.consumereagle.com - July 12 at 6:11 PM
News IconHC Stocks Reports Analysis: aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE)
sharemarketupdates.com - July 12 at 6:11 PM
News IconAtyr Pharma Incorporated (NASDAQ:LIFE) Shorts Decreased by 6.41% After Short Covering - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - July 6 at 6:10 PM
News IconWere Analysts Bearish aTyr Pharma Inc (NASDAQ:LIFE) This Week? - Press Telegraph (NASDAQ:LIFE)
presstelegraph.com - July 5 at 10:33 AM
News IconWhat Next for aTyr Pharma Inc Stock After Today's Huge Decline? - Press Telegraph (NASDAQ:LIFE)
presstelegraph.com - June 29 at 5:49 PM
News IconShares Up in Session: aTyr Pharma Inc. (NASDAQ:LIFE) - Telanagana Press (NASDAQ:LIFE)
telanaganapress.com - June 29 at 5:49 PM
News IconWatching Stock Volatility for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE)
www.engelwooddaily.com - June 29 at 5:49 PM
News IconAtyr Pharma Incorporated (NASDAQ:LIFE) Short Interest Decreased By 6.41% - Press Telegraph (NASDAQ:LIFE)
presstelegraph.com - June 28 at 10:49 AM
prnewswire.com logoGlobal Tuberculosis Pipeline 2016 Market Report on 64 Companies - PR Newswire (press release) (NASDAQ:LIFE)
www.prnewswire.com - June 17 at 8:43 AM
biz.yahoo.com logoATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:LIFE)
biz.yahoo.com - June 16 at 5:17 PM
capitalcube.com logoaTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 (NASDAQ:LIFE)
www.capitalcube.com - June 10 at 5:01 PM
news.cmlviz.com logoATYR PHARMA INC. (NASDAQ:LIFE) Financial Condition Compared to S&P 500 - CML News (NASDAQ:LIFE)
news.cmlviz.com - June 8 at 6:16 PM
News IconAtyr Pharma Incorporated (NASDAQ:LIFE) Shorted Shares Increased By 7.31% - HNN (NASDAQ:LIFE)
hintsnewsnetwork.com - June 3 at 6:21 PM
News IconaTyr Pharma Inc (NASDAQ:LIFE) Stock Update & Estimates - Stock Tick Tock (NASDAQ:LIFE)
www.stockticktock.com - June 3 at 6:21 PM
stockhouse.com logoaTyr Pharma to Present at Jefferies 2016 Healthcare Conference - Stockhouse (NASDAQ:LIFE)
www.stockhouse.com - June 3 at 8:43 AM
investornewswire.com logoaTyr Pharma Inc (NASDAQ:LIFE) Quarterly EPS Estimate At $-0.74 - Investor Newswire (NASDAQ:LIFE)
www.investornewswire.com - June 2 at 6:15 PM
biz.yahoo.com logoATYR PHARMA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:LIFE)
biz.yahoo.com - May 26 at 4:01 PM
kcregister.com logoFast Moving Stocks: aTyr Pharma (NASDAQ:LIFE), Public Service Enterprise Group (NYSE:PEG), ShoreTel, (NASDAQ ... - KC Register (NASDAQ:LIFE)
www.kcregister.com - May 23 at 12:52 PM
stocksdaily.net logoaTyr Pharma Inc (NASDAQ:LIFE) One-Year Price Target At $9.00 - Stocks Daily (NASDAQ:LIFE)
www.stocksdaily.net - May 23 at 12:52 PM
stocksdaily.net logoaTyr Pharma Inc (NASDAQ:LIFE) Comprehensive Income At $-0.171 - Stocks Daily (NASDAQ:LIFE)
www.stocksdaily.net - May 18 at 12:35 AM
investornewswire.com logoaTyr Pharma Inc (NASDAQ:LIFE) One-Year Price Projection At $8 - Investor Newswire (NASDAQ:LIFE)
www.investornewswire.com - May 16 at 1:00 PM
fidaily.com logoaTyr Pharma, Inc. (NASDAQ:LIFE) Is Trading Down – Insider Trading Activity (NASDAQ:LIFE)
www.fidaily.com - May 13 at 1:13 AM
publicnow.com logoaTyr Pharma Announces First Quarter 2016 Operating Results (NASDAQ:LIFE)
www.publicnow.com - May 11 at 5:07 PM
sg.finance.yahoo.com logoAtyr Pharma reports 1Q loss (NASDAQ:LIFE)
sg.finance.yahoo.com - May 11 at 4:22 PM
biz.yahoo.com logoATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financia (NASDAQ:LIFE)
biz.yahoo.com - May 11 at 4:08 PM
stocksdaily.net logoaTyr Pharma Inc (NASDAQ:LIFE) Comprehensive Income At $-0.171 For Period Ended 2015-12-31 - Stocks Daily (NASDAQ:LIFE)
www.stocksdaily.net - May 10 at 8:01 PM
News IconHC Sector Updates: Dynavax Technologies Corporation (DVAX), IDEXX Laboratories Inc. (IDXX), aTyr Pharma Inc (LIFE) - share market updates (press release) (NASDAQ:LIFE)
sharemarketupdates.com - May 10 at 8:01 PM
investornewswire.com logoaTyr Pharma Inc (NASDAQ:LIFE) One-Year Mean Price Target At $8 - Investor Newswire (NASDAQ:LIFE)
www.investornewswire.com - May 10 at 12:59 AM
News IconHC Stocks Alerts: aTyr Pharma Inc (LIFE), Cytori Therapeutics Inc (CYTX), CytRx Corporation (CYTR) - share market updates (press release) (NASDAQ:LIFE)
sharemarketupdates.com - May 6 at 8:00 PM

Social

Atyr Pharma (NASDAQ:LIFE) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff